GlassScriptPhysician profile
Wolfgang Singer
NPI 1720052632
$127,754.54
in general payments reported to CMS, 2019-2025
12 companies · $13K in 2025
The $13K reported for 2025 was more than what 91% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $30K · 2022: $4,520 · 2024: $58K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $51K · Travel and Lodging: $16K · Consulting Fee: $2,990 · Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $50,616.00 |
| Travel and Lodging | $16,455.16 |
| Consulting Fee | $2,990.00 |
| Food and Beverage | $626.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| H. Lundbeck A S | $112,214.60 | 2019-2025 | |
| Catalyst Pharmaceuticals, INC. | $5,937.41 | 2020 | |
| Ionis Pharmaceuticals, INC. | $2,990.00 | 2025 | |
| Amneal Pharmaceuticals LLC | $2,500.00 | 2022 | |
| Janssen Global Services, LLC | $2,020.00 | 2022 | |
| Astellas Pharma INC | $2,000.00 | 2019 | |
| Lundbeck LLC | $92.53 | 2024 |
5 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wolfgang Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.